Cepheid

“Because smells like it… isn’t a diagnosis.” When patients present with vaginitis symptoms, they’re looking to you for clear answers—not variability. Even though Amsel’s criteria are a standard for BV, differences in clinical assessment can create diagnostic challenges that may impact clinical management and follow-up. Xpert® Xpress MVP (Multiplex Vaginal Panel) detects DNA targets associated with BV, Candidiasis, and Trichomoniasis—in ~60 minutes.

Learn more at: https://ow.ly/OgWe50Z8XpI

Join the Cepheid symposium at the 11th FIDSSA Congress as we explore how rapid PCR is transforming the diagnosis and management of GI infections. With overlapping symptoms and delayed results still challenging clinical care, there’s a growing need for fast, actionable insights to guide treatment and improve outcomes.

🕒 19 June 2026 |12:30–13:30 |
📍 Meeting Room 1.41-14.2, CTICC, Cape Town

Hear from our speakers as they unpack clinical challenges and the role of syndromic testing and integrated diagnostic approaches.

👉 Join us to discover how faster diagnostics can support better patient outcomes

📢 Cepheid is committed to supporting the global response to the Ebola Bundibugyo (BDBV) outbreak. Xpert® Hemorrhagic Fever panel tests are now available in Africa, helping strengthen diagnostic capacity in the Democratic Republic of the Congo and Uganda following the WHO’s Public Health Emergency of International Concern declaration on May 17, 2026.

📰Read the full press release: https://ow.ly/714550Zb5gQ

IVD. In Vitro Diagnostic Medical Device. Not available in all countries.

🧫 Catching Resistance Before It Spreads. Humanitas Research Hospital in Milan, Italy, is tackling rising drug‑resistant infections with early molecular screening, identifying carriers sooner, preventing outbreaks, and protecting vulnerable patients. Faster results and targeted action are helping the team stay ahead of MDROs while optimizing hospital resources.

📰 Read the full article to learn how early screening strengthens prevention:
https://ow.ly/BmJy50Z5mFy

💡At ESCMID Global 2026, Cepheid explored a critical question facing modern diagnostics: How do we balance precision today with the power of what’s next? In our integrated symposium, we took a practical look at diagnostic stewardship, from smart panels to metagenomics, and their role in clinical decision-making.

Missed the session? Catch up on the conversation: 🔗 https://ow.ly/t2V550Z7Qtj